4//SEC Filing
KURLAND FRED 4
Accession 0001104659-18-072394
CIK 0001614067other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 5:13 PM ET
Size
5.2 KB
Accession
0001104659-18-072394
Insider Transaction Report
Form 4
KURLAND FRED
Chief Financial Officer
Transactions
- Award
Stock Options
2018-12-05+17,000→ 40,024 totalExercise: $8.50Exp: 2028-12-05→ Common Stock (17,000 underlying)
Footnotes (1)
- [F1]The shares underlying this stock option vest as follows: in equal annual installments over the 48 months following the date of grant.
Documents
Issuer
Aridis Pharmaceuticals, Inc.
CIK 0001614067
Entity typeother
Related Parties
1- filerCIK 0001267273
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 5:13 PM ET
- Size
- 5.2 KB